A comparative public health and budget impact analysis of pneumococcal vaccines. The french case

Value Health. 2014 Nov;17(7):A668. doi: 10.1016/j.jval.2014.08.2467. Epub 2014 Oct 26.

Authors

Y Jiang¹, F Gervais¹, A Gauthier¹, C Baptiste², P Martinon³, X Bresse²

Affiliations

¹ Amaris, London, UK.
² Sanofi Pasteur MSD, Lyon, France.
³ SANOFI PASTEUR MSD, LYON, France.

PMID: 27202446
DOI: 10.1016/j.jval.2014.08.2467

No abstract available